BRIEF-Shenzhen Hepalink Pharma sees Q1 profit down 40-50 pct y/y

April 15 Tue Apr 15, 2014 12:33am EDT

Related Topics

April 15 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd

* Says expects Q1 net profit down 40-50 percent y/y at 69.6-83.5 million yuan ($11.19-13.43 million) versus 139.1 million yuan previous year

Source text in Chinese: link.reuters.com/dek58v

Further company coverage: ($1 = 6.2191 Chinese Yuan) (Reporting by Hong Kong newsroom)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.